We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Joshua Korzenik

Joshua Korzenik MD

Assistant Professor of Medicine, Harvard Medical School; Director, Brigham and Women’s Hospital, Crohn’s and Colitis Center, Boston, Massachusetts

Dr. Joshua Korzenik is an Assistant Professor of Medicine at Harvard Medical School and Director of the BWH Crohn’s and Colitis Center.  In his role as head of the IBD program, he takes care of patients with IBD, directs the IBD Fellowship, mentors fellows and guides a broad clinical and research program in IBD.  He received his bachelor’s degree from Harvard College and his M.D. degree from Albert Einstein College of Medicine.  He has published over 100 studies, reviews, and editorials on Inflammatory Bowel Disease with a focus on clinical care, epidemiology, translational research and novel therapeutics for IBD.  As Principal Investigator, he directs an innovative program to develop a novel approach to care for IBD with a broadly integrated program to address the psychosocial issues.  He has directed and is a co-investigator on numerous clinical trials for therapeutics in IBD with studies early on identifying a role of the innate immune system in Crohn’s disease with trials of GM-CSF.  His efforts also include being the principle investigator or co-investigator on several important studies to understand the risk factors for the development of IBD or flares of the disease, including diet and exercise.  As PI of a grant from the CCFA, he recently completed a study investigating the epidemiologic risk factors associated with rise of IBD in India.

Dr. Korzenik  chairs the Patient Education Committee for the National Medical Advisory Board for the Crohn’s and Colitis Foundation of America and serves on their Quality Improvement Committee as well.  He serves on the local CCFA New England Chapter both on its medical advisory board and New England Board.  He was awarded Humanitarian of the Year by the chapter in 2013.  He serves as a reviewer for the New England Journal of Medicine, Clinical Gastroenterology and Hepatology and the IBD Journal among others.